EGFR Inhibitors - Medscape

Read about ways in which mutational analysis of material obtained from patients with lung cancer could be optimized and how to select those patients who would benefit from treatment.
The damned singles Singletrails rosenheim

EGFR Inhibitors - Medscape

Re: Single agent herceptin

Herceptin® (trastuzumab), Kadcyla®(ado-trastuzumab) and. Herceptin ® (trastuzumab), Kadcyla ® Aetna Precertification Notification 503 Sunport Lane, Orlando, FL 32809 (ado-trastuzumab) and Perjeta ® (pertuzumab)

EGFR Inhibitors - Medscape

Re: Single agent herceptin

Trastuzumab Genentech Herceptin HERCEPTIN ® Trastuzumab WARNING CARDIOMYOPATHY: HERCEPTIN administration can result in the development of ventricular dysfunction and congestive heart failure.

EGFR Inhibitors - Medscape

Re: Single agent herceptin

Southern Pathology – Knowledge From People Who Care Test Description. After a diagnosis of metastatic breast cancer has been made, Her-2neu testing may be used as a prognostic marker to help determine how aggressive the breast cancer tumor is likely to be.

EGFR Inhibitors - Medscape

Re: Single agent herceptin

Herceptin (Tratuzumab) Package Insert WARNING CARDIOMYOPATHY: HERCEPTIN administration can result in the development of ventricular dysfunction and congestive heart failure. Left ventricular function should be evaluated in all patients prior to and during treatment with HERCEPTIN.

EGFR Inhibitors - Medscape

Re: Single agent herceptin

Paclitaxel - FDA prescribing information, side effects and. The adverse event profile for patients receiving Paclitaxel in combination with cisplatin in these studies was qualitatively consistent with that seen for the pooled analysis of data from 812 patients treated with single-agent Paclitaxel in 10 clinical studies.

EGFR Inhibitors - Medscape

Re: Single agent herceptin

Treatment Side Effects of Herceptin® (trastuzumab) for. Adjuvant Breast Cancer Treatment Side Effects Adverse reactions in Herceptin clinical studies 1. In Study 1, only grade 3-5 adverse events, treatment‑related grade 2 events, and grade 2-5 dyspnea were collected during and for up to 3 months following protocol‑specified treatment.

EGFR Inhibitors - Medscape

Re: Single agent herceptin

NCT00781612 - Participants will receive trastuzumab emtansine either as a single agent or in combination with other anti-cancer therapy (pertuzumab, paclitaxel, trastuzumab and docetaxel).

EGFR Inhibitors - Medscape

Re: Single agent herceptin

Trastuzumab emtansine - Wikipedia Trastuzumab emtansine also known as ado-trastuzumab emtansine and sold under the trade name Kadcyla, is an antibody-drug conjugate consisting of the humanized monoclonal antibody trastuzumab (Herceptin) covalently linked to the cytotoxic agent DM1.

EGFR Inhibitors - Medscape

Re: Single agent herceptin

Herceptin® (trastuzumab) Breast Cancer, Metastatic Gastric. Information for healthcare professionals about Herceptin® (trastuzumab) for the treatment of HER2+ adjuvant breast cancer, metastatic breast cancer, metastatic gastric cancer, and gastroesophageal junction (GEJ) adenocarcinoma. See full safety for more information.